News - Teva Pharmaceutical Industries, Nerventra

Filter

Popular Filters

EMA/CHMP January meeting highlights

EMA/CHMP January meeting highlights

24-01-2014

There were a number of positive, and negative, opinions issued on January 24, following the monthly meeting…

AB ScienceAdempasBayerBemfolaDainippon Sumitomo PharmaEuropeFinox BiotechHemoprostolLatudaLinepharmaMasivieraNerventraNovartisPTC TherapeuticsReasanzRegulationTakeda PharmaceuticalsTeva Pharmaceutical IndustriesTranslarna

Back to top